LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

Merge Labs is a “research lab” dedicated to “bridging biological and artificial intelligence to maximize human ability.” ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

As the momentum and interest in brain-computer interface (BCI) technologies continue to accelerate, Merge Labs has emerged ...

A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The new BCI solution has been implanted in over 50 patients.

OpenAI leads a major seed round in Sam Altman’s Merge Labs to develop advanced, non-invasive brain-computer interfaces with ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

OpenAI is investing in Sam Altman's BCI startup Merge Labs, which aims to enhance human capabilities through innovative brain ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

The MarketWatch News Department was not involved in the creation of this content. Verified Market Research(R) a leading provider of business intelligence and market analysis is thrilled to announce ...

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...